Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Cancer Prevention and Treatment
1673-5269
2009 Issue 14
Current understanding of radiation-induced esophageal injury
ZHOU Xia;ZHENG Xiao Department of Radiotherapy;Zhejiang Cancer Hospital;Hangzhou 310022;P.R.China
..............page:1113-1117
Research of establishing a mouse model of femur cancer pain with Lewis lung cancer cell lines
BAI Hua1;LI Zhong1;CHEN Wei-wu2;JIANG Miao1;ZHANG Ya-yue11.Department of Hematology;Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine;Beijing 100700;P.R.China2.Qizheng Tibetan Medicine Marketing Ltd;Lhasa 850000;P.R.China
..............page:1062-1065
Trend of mortality rate of malignant tumors in 15 years and its recent predictive analysis in Gansu Province
LIU Yu-qin1;ZHANG Xiao-dong1;YAN Jun2;WANG Xiao-hui11.Department of Cancer Epidemiology;Medical Science Insititute of Gansu;Lanzhou 730000;P.R.China 2.School of Public Health;Lanzhou University;Lanzhou 730000;P.R.China
..............page:1045-1050
Survivin-mediated sensitizing effect of tunicamycin on TRAIL in thyroid cancer cells
DU Zhen-xian1;ZHANG Hai-yan1;DENG Wei-wei1;WANG Hua-qin21.First Affiliated Hospital;China Medical University;Shenyang 110001;P.R.China2.Department of Biochemistry & Molecular Biology;China Medical University;Shenyang 110001;P.R.China
..............page:1041-1044
jie ru zhi liao lian he fang hua liao zhi liao ju xian qi xiao xi bao fei ai 28 li jin qi liao xiao fen xi
zhao yong li song ji fu wei xiu e zhou hong mei li kai yan
..............page:1118-1119
Expressions of OPN and p21ras in breast carcinoma and their relationship with prognosis
GAO Ya-li;XING Lu-qi Department of Pathology;First Affiliated Hospital of Henan University of Science and Technology;Luoyang 471003;P.R.China
..............page:1079-1081
Expressions and clinical significance of CD15,CD44V6 and PCNA in breast carcinoma tissues
TIAN Bin1;NIU Hu21.Department of Breast Surgery;Jinan Central Hospital;Shandong University;Jinan 250013;P.R.China2.Department of Breast and Thyroid Surgery;Jinan No.4 People’s Hospital;Jinan 250031;P.R.China
..............page:1082-1085
Clinical implication of high level expression of Rad51 in non-small cell lung cancer
QIAO Gui-bin;ZENG Wei-sheng;PENG Li-jun;WU Yi-long Department of Thoracic Surgery and Guangdong Lung Cancer Institute;Guangzhou General Hospital of Guangzhou Military Command;Guangzhou 510010;P.R.China
..............page:1086-1089,1100
Effect of genetically modified adenovirus H101 on nude mice model of osteosarcoma with lung metastasis
XU Li-hui;CAI You-bo;WANG Di-fan Department of Orthopaedic Oncology;Fourth Teaching Hospital of Peking University ;Beijing 100035;P.R.China
..............page:1066-1068
Expression of APE/Ref-1 protein in non-small cell lung cancer and its clinical signficance
SANG Chong-ling;LI Qiang Department of Respiratory Medicine;Changhai Hospital of the Second Military Medical University;Shanghai 200433;P.R.China
..............page:1090-1092
Relationship between Survivin expression and prognosis of patients with esophageal squamous cell carcinoma receiving chemoradiotherapy
HUANG Wei-zhao1;2;LIU Meng-zhong1;HU Yi1;YANG Hong1;ZHENG Bin1;WANG Geng1;LUO Kong-jia1;WEN Jing1;FU Jian-hua11.State Key Laboratory of Oncology in Southern China;Cancer Center;Sun Yat-Sen University;Guangzhou 510089;P.R.China2.Department of Cardiothoracic Surgery;Zhongshan Hospital of Sun Yat-Sen University;Zhongshan 528400;P.R.China
..............page:1097-1100
Clinical significance of expressions of SKP2 and p16 proteins in lung carcinoma tissues
ZHAO Jun1;2;DING Wei-zhong2;LIU Jing-yi2;WANG Pen-hang2;LIU Zhi-ping2;YANG Chun-lu11.Department of Thoracic Surgery;First Affiliated Hospital of China Medical Univercity;Shenyang 110001;P.R. China2.Department of Thoracic Surgery;Shenyang Municipal Thoracic Hospital;Shenyang 110044;P.R.China
..............page:1093-1096
Clinical application of piliated pseudomonas aeruginosa for breast cancer patients after operation with seroma formation
MA Fu-yi;WANG Li-quan;WANG Chang-liang;LIN Ming-zhen Department of Oncosurgery;Weifang People’s Hospital;Weifang 261041;P.R.China
..............page:1111-1112,1119
Diagnosis and treatment of undifferentiated embryonal srcoma of the liver in children:14 cases
QIN Hong;ZHU Xiu-dan;WANG Huan-min;ZHANG Jin-zhe;LIU Tao Department of Surgery;Beijing Children’s Hospital;Capital Medical University;Beijing 100045;P.R. China
..............page:1108-1110
Molecular mechanism of SKP2 promoting cervical cancer HeLa cell proliferation
DUAN Zhao;ZHU Gai-xia;YANG Dong-mei;ZHANG Xin;GAO Ya Department of Obstetrics and Gynecology;Second Hospital of Xi’an Jiaotong University;Xi’an 710004;P.R.China
..............page:1069-1073
Effects of dihydroartemisinin on proliferation and apoptosis of breast carcinoma cell line T47D
GU Hong-tao1;MAO Hai-ting2;ZHANG Ling1;WEN Pei-e1;XU Xiao-qun1;LI Cui-ling1;YIN Hai-peng11.Key Medical Laboratory for Tumor Immunology & Chinese Medicine Immunology of Shandong Province;Key Laboratory for Modern Medicine and Technology of Shandong Province;Institute of Basic Medicine;Shandong Academy of Medical Science;Jinan 250062;P.R.China2.Basic Research Institute of Medicine;Qilu Hospital;Shandong University;Jinan 250012;P.R.China
..............page:1051-1054
PTEN-mediated resistance to tyrosine kinase inhibitors in lung cancer cell lines H-157 and H-1355
ZHUANG Hong-qing;WANG Jun;YUAN Zhi-yong;ZHAO Lu-jun;WANG Ping;YU Jin-pu;REN Xiu-bao;WANG Chang-li Department of Radiotherapy;Tianjin Cancer Institute & Hospital;Tianjin Lung Cancer Center;Key-Lab of Cancer Prevention and Therapy;Tianjin 300060;P.R.China
..............page:1055-1058
Expressions of biomarkers in breast invasive ductal carcinoma and their clinicopathological significance
WANG Zhan-bo;ZHAO Po;LI Xiang-hong Department of Pathology;Chinese PLA General Hospital;Beijing 100853;P.R.China
..............page:1074-1078
Effects of inhibition of ERCC1 expression by RNA interference on chemotherapy sensitivity of lung cancer A549 cell line
PAN Hong;ZUO Chuan-tian;LI Li;MAO Nai-quan;ZHANG Wei;TANG Bu-jian Department of Thoracic;Tumor Affiliated Hospital of Guangxi Medical University;Nanning 530021;P.R.China
..............page:1059-1061
Sequential and concurrent radiochemotherapy for stage Ⅲ non-small cell lung cancer
ZHU LI;WU Rong Cancer Center;Shengjing Hospital of China Medical University;Shenyang 110022;P.R.china
..............page:1105-1107
Effect of tumor-associated macrophages on endometrioid adenocarcinoma tissues
BAI Xue1;ZHANG Ming-fang1;2;ZHANG Yu-jie2;LI Lin1;ZHANG Yun-sha1;LI Wei11.Department of Pathology;Tianjin Medical University;Tianjin;300070;P.R. China2.Department of Pathology;General Hospital of Tianjin Medical University;Tianjin;300052;P.R. China
..............page:1101-1104